|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Sorafenib inhibits imatinib-resistant KIT and platelet-derived growth factor receptor beta gatekeeper mutants 显示文摘 | Guida T Anaganti S Provitera L | 2007 | Clin Cancer Res2007，13，： | 1 |
| 2 | Sensory deficit in Parkinson's disease:evidence of a cutaneous denervation 显示文摘 | NOLANO M PROVITERA V ESTRANEO A | 2008 | Brain2008，131，： | 1 |
| 3 | Differential trigeminal my- elinated and unmyelinated nerve fiber involvement in FOSMN syn- drome显示文摘 | Truini A Provitera V Biasiotta A et at | 2015 | Neurology2015，84，： | 1 |
| 4 | Mitogenic Effects of the Up-Regulation of Minichromosome Maintenance Proteins in Anaplastic Thyroid Carcinoma显示文摘 | Teresa Guida Giuliana Salvatore Pinuccia Faviana Riccardo Giannini Ginesa Garcia-Rostan Livia Provitera Fulvio Basolo Alfredo Fusco Francesca Carlomagno Massimo Santoro | 2005 | The Journal of Clinical Endocrinology & Metabolism2005，，8： | 1 |
| 5 | Quantification of myelinated endings and mechanoreceptors in human digital skin显示文摘 | Nolano M Provitera V Crisci C | 2003 | Ann Neurol2003，54，： | 1 |
| 6 | RET is a heat shock protein 90 (HSP90) client protein and is knocked down upon HSP90 pharmacological block显示文摘 | Alfano L Guida T Provitera L | 2010 | J Clin Endocrinol Metab2010，95，7： | 1 |
| 7 | RET is a heat shock protein 90 (HSP90) chient protein and is knocked down upon HSP90 pharma- cological block显示文摘 | A|fano L Guida T Provitera L et a/ | 2010 | J Clin Endocrinol Metub2010，95，4： | 1 |
| 8 | Evaluation of sudonotor function in diabetes using the dynamic sweat test显示文摘 | Provitera V Nolano M Caporaso G | | 0，，： | 1 |
| 9 | Quantification of pilomotor nerves:a new tool to evaluate autonomic involvement in diabetes显示文摘 | Nolano M Provitera V Caporaso G | | 0，，： | 1 |
| 10 | Possible role of transforming growth factor-beta in relapsing-remitting multiple sclerosis显示文摘 | Provitera V Bruno R | 1997 | Neurol Res1997，19，6： | 1 |
| 11 | Small fiber involvement in Fried- reichs ataxia显示文摘 | Nolano M Provitera V Crisci C | 2001 | Ann Neurol2001，50，： | 1 |
| 12 | Quantification of myelinated endings and mechanoreceptors in human digital skin显示文摘 | Nolano M Provitera V Crisci C | 2003 | Ann Neurol2003，54，： | 1 |
| 13 | Ross syndrome: a rare or a misknown disorder of thermoregulation? A skin innervation study on 12 subjects显示文摘 | Nolano M Provitera V Perretti A | 2006 | Brain2006，129，8： | 1 |
| 14 | Ross syndrome: a rare or a misknown disorder of thermoregulation? A skin innervation study on 12 subjects显示文摘 | Nolano M Provitera V Perretti A | 2006 | Brain2006，129，： | 1 |
| 15 | Sensory deficit in Parkinson,s disease:evidence of a cutaneous denervation显示文摘 | Nolano M Provitera V Estraneo A | 2008 | Brain2008，131，7： | 1 |
| 16 | Sorafenib inhibits imatinib-resistant KIT and platelet-derived growth factor receptor beta gatekeeper mutants显示文摘 | Guida T Anaganti S Provitera L | | 0，，11： | 1 |
| 17 | Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis:a correlation with clinical activity显示文摘 | Provitera V De Rosa T Tartaglia G | 1998 | Immunopharmacol Immunotoxicol1998，20，3： | 1 |
| 18 | Binding of equine infectious anemia virus matrix protein to membrane bilayers involves multiple interactions 显示文摘 | Provitera P Bouamr F Murray D | 2001 | Mol Biol2001，296，： | 1 |
| 19 | Small-fiber involvement in spinobulbar muscular atrophy ( Kennedy's disease) 显示文摘 | Manganelli F Iodiee V Provitera V | 2007 | Muscle Nerve2007，36，6： | 1 |
| 20 | Ross综合征是否为一种罕见且常被误解的体温调节障碍疾病:12例患者皮肤神经支配研究显示文摘Ross syndrome is described as a rare disorder of sweating associated with areflexia and tonic pupil. Since Ross’s first description in 1958, ~40 cases have been described. We assessed the involvement of cutaneous innervation in 12 subjects with Ross syndrome using quantitative sensory testing, sweating assessment and immunohistochemical study of anhidrotic and hyperhidrotic skin. This evaluation was repeated over time in 4 out of 12 subjects. In addition, we enrolled four subjects with Holmes-Adie syndrome (areflexia and tonic pupil)to investigate similarities between the two conditions. We found in Ross patients a complex and progressive involvement of cutaneous sensory and autonomic innervation underlying the impairment of heat production and heat dissipation through both loss of sweating and loss of cutaneous blood flow regulation. In Holmes-Adie subjects we found a mild impairment of sweating without thermoregulatory problems. The persistence of a sudomotor vasoactive intestinal peptide-immunoreactive (VIP-ir) innervation, although deranged and poor, definitely differentiated Holmes-Adie from Ross patients. Ross syndrome is a progressive and complex disorder of thermoregulation difficult to differentiate from the probably pathogenetically related Holmes-Adie syndrome. Sweating assessment and skin biopsy are suitable tools to define a boundary between them. Owing to the large number of Ross patients observed in only 5 years, and to the long and complex medical history of most of them, doubts arise on the effective rarity of this condition, and we warn family doctors and other specialists, besides neurologists, to become aware of this complex disorder. | Nolano M. Provitera V. Perretti A. 张磊 | 2006 | 世界核心医学期刊文摘(眼科学分册)2006，2，12： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员